Different mechanisms are involved in the antibody mediated inhibition of ligand binding to the urokinase receptor: a study based on biosensor technology
- 1 January 1999
- journal article
- Published by Elsevier in Journal of Immunological Methods
- Vol. 222 (1-2) , 125-133
- https://doi.org/10.1016/s0022-1759(98)00189-6
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Photoaffinity Labeling of the Human Receptor for Urokinase-Type Plasminogen Activator Using a Decapeptide Antagonist. Evidence for a Composite Ligand-Binding Site and a Short Interdomain SeparationBiochemistry, 1998
- Characterization of Monoclonal Antibodies that Strongly Inhibit Electrophorus Electricus AcetylcholinesteraseEuropean Journal of Biochemistry, 1995
- A Library of Monoclonal Antibodies to Escherichia coli K-12 Pyruvate Dehydrogenase ComplexJournal of Biological Chemistry, 1995
- The urokinase receptor. Protein structure and role in plasminogen activation and cancer invasionFibrinolysis, 1994
- The urokinase receptor: Structure, regulation and inhibitor-mediated internalizationFibrinolysis, 1994
- Ligand Interaction between Urokinase-Type Plasminogen Activator and Its Receptor Probed with 8-Anilino-1-naphthalenesulfonate. Evidence for a Hydrophobic Binding Site Exposed Only on the Intact ReceptorBiochemistry, 1994
- Inhibition of metastasis of lewis lung carcinoma by a synthetic peptide within growth factor‐like domain of urokinase in the experimental and spontaneous metastasis modelInternational Journal of Cancer, 1994
- Plasminogen activators and plasminogen activator inhibitors in human colorectal carcinoma tissues are not expressed by the tumour cellsEuropean Journal Of Cancer, 1993
- Kinetic analysis of monoclonal antibody-antigen interactions with a new biosensor based analytical systemJournal of Immunological Methods, 1991
- A better cell line for making hybridomas secreting specific antibodiesNature, 1978